Pricing Log in Create free account

BioAtla, Inc. (BCAB) vs Mustang Bio, Inc. (MBIO)

BioAtla, Inc. and Mustang Bio, Inc. are both Biotechnology companies. BioAtla, Inc. and Mustang Bio, Inc. are of similar size ($2.9M and $2.9M). Mustang Bio, Inc. has the higher net margin (0.00% vs −177.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Mustang Bio, Inc. leads on 8 and BioAtla, Inc. on 3.

Valuation

Metric BCAB MBIO Biotechnology median
P/E n/m n/m 8.50
P/S 0.13 n/m 9.71
P/B n/m 0.34 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 0.63 n/m 9.21
Earnings yield (1,871.32%) (118.42%) (33.15%)
Free cash flow yield (1,044.09%) (147.00%) (25.50%)

Profitability

Metric BCAB MBIO Biotechnology median
Gross margin 95.44% 0.00% 65.16%
Operating margin (180.99%) 0.00% 0.00%
Net margin (177.21%) 0.00% 0.00%
Free cash flow margin (132.29%) 0.00% 0.00%
Return on equity 118.74% (58.12%) (56.36%)
Return on assets (171.72%) (21.17%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BCAB MBIO Biotechnology median
Revenue growth (TTM) 574.65% — 6.02%
EPS growth (last fiscal year) 29.86% 98.49% 30.26%
Revenue growth, 5-year CAGR (28.40%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCAB MBIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.20 1.97 4.72
Net debt to EBITDA 0.12 7.22 0.96

Dividend

Metric BCAB MBIO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BCAB MBIO Biotechnology median
Market cap 2.89m 2.92m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack